Downregulation of serum Foxc2 in dilated cardiomyopathy: association with disease severity and cardiac function
Foxc2 may serve as a promising biomarker for DCM diagnosis and prognosis, supporting for further mechanistic investigations.
Authors
- Guixian Guo
- Qiuhua Huang (ORCID: https://orcid.org/0000-0002-5701-0117)
- Yuyan Cai (ORCID: https://orcid.org/0000-0002-2028-4763)
- Mingfeng Huang (ORCID: https://orcid.org/0000-0001-8576-2001)
- Tang Xiao-yan (ORCID: https://orcid.org/0000-0003-1057-4262)
- Shaobin Zhi
Institutions
- Meizhou City People's Hospital (CN)
- Meizu (China) (CN)
- Key Laboratory of Guangdong Province (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
Publication Details
- Journal
- Future Science OA
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1080/20565623.2025.2552085
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00